Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Page 19

Private Equity

Fumigation Chems Maker Douglas Returns to Block

By Tom Terrarosa
|
Published: May 2nd, 2023
Altamont Capital Partners has stuck with Evercore and put the fumigation chemicals supplier back on the auction block, The Deal has learned.
Activism

Activist Investing Today: T. Rowe’s Anderson Talks Insurgencies

By Ronald Orol
|
Published: April 13th, 2023
The chief of corporate governance for the asset manager explains why it will speak publicly about certain deals and why companies facing activists might want to think about visiting her before traveling to see a nearby proxy adviser.
M&A

FatBeam Finds European Buyer

By Chris Nolter
|
Published: April 10th, 2023
Basalt Infrastructure is the latest overseas infrastructure investor to back a U.S. telecom infrastructure company.
Private Equity

Orangewood Taps Auditor Amid Regulator Feeding Frenzy

By Quratulain Tejani
|
Published: April 10th, 2023
The New York sponsor has been on the hunt for outsourced compliance services businesses for at least a year and views today's environment as strengthening the thesis around its minority investment in New Jersey auditing firm DLA.
M&A

Raymond James Eyes Expansion in Healthcare

By Armie Margaret Lee
|
Published: April 10th, 2023
The St. Petersburg, Fla.-based firm has made several hires since August, most recently adding three healthcare services bankers from Coker Capital.